ATPC vs. TOI, CCM, MRAI, ATIP, BRTX, KDLY, OTRK, OPGN, MGRX, and BGLC
Should you be buying Agape ATP stock or one of its competitors? The main competitors of Agape ATP include Oncology Institute (TOI), Concord Medical Services (CCM), Marpai (MRAI), ATI Physical Therapy (ATIP), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Ontrak (OTRK), OpGen (OPGN), Mangoceuticals (MGRX), and BioNexus Gene Lab (BGLC). These companies are all part of the "healthcare" industry.
Agape ATP vs.
Oncology Institute (NASDAQ:TOI) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability, community ranking and analyst recommendations.
Oncology Institute presently has a consensus target price of $2.50, suggesting a potential upside of 354.55%. Given Oncology Institute's stronger consensus rating and higher possible upside, equities analysts clearly believe Oncology Institute is more favorable than Agape ATP.
Oncology Institute received 4 more outperform votes than Agape ATP when rated by MarketBeat users.
Agape ATP has lower revenue, but higher earnings than Oncology Institute. Agape ATP is trading at a lower price-to-earnings ratio than Oncology Institute, indicating that it is currently the more affordable of the two stocks.
In the previous week, Agape ATP had 1 more articles in the media than Oncology Institute. MarketBeat recorded 1 mentions for Agape ATP and 0 mentions for Oncology Institute. Agape ATP's average media sentiment score of 0.09 beat Oncology Institute's score of -0.71 indicating that Agape ATP is being referred to more favorably in the news media.
36.9% of Oncology Institute shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 9.5% of Oncology Institute shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Oncology Institute has a beta of 0.13, meaning that its stock price is 87% less volatile than the S&P 500. Comparatively, Agape ATP has a beta of 2.13, meaning that its stock price is 113% more volatile than the S&P 500.
Oncology Institute has a net margin of -17.63% compared to Agape ATP's net margin of -194.09%. Agape ATP's return on equity of -74.71% beat Oncology Institute's return on equity.
Summary
Oncology Institute beats Agape ATP on 10 of the 17 factors compared between the two stocks.
Get Agape ATP News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATPC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Agape ATP Competitors List
Related Companies and Tools
This page (NASDAQ:ATPC) was last updated on 1/21/2025 by MarketBeat.com Staff